Molecular Diagnostics - Cancer Genomics Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What type of disease is cancer classified as?

A

Cancer is a genetic disease: both inherited and somatic (acquired).

This classification highlights that cancer can arise from genetic mutations passed down through generations or acquired during an individual’s life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many ‘driver’ mutations can be present in cancer?

A

Up to 10-20 ‘driver’ mutations.

Driver mutations are genetic alterations that contribute to the development and progression of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the significance of sequencing genomes in cancer research?

A

Sequence genomes (cancer tissue and normal) to find genetic changes and suggest possible therapies.

This process helps identify specific mutations that may be targeted for treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are somatic mutations?

A

Somatic mutations are inherited throughout a lifetime.

These mutations occur in non-germline cells and are not inherited by offspring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are germline mutations?

A

Germline mutations are inherited cancer mutations.

These mutations are present in the reproductive cells and can be passed to the next generation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a key factor that leads to cancer development?

A

Polymerase makes mistakes in key genes involved in cell proliferation.

Errors in DNA replication can lead to the accumulation of mutations that promote cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What advantage do tumor cells gain from mutations?

A

Tumor cells gain a selective growth advantage.

This advantage allows cancer cells to proliferate more rapidly than normal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or False: The same type of cancer can have different mutations in different patients.

A

True.

Each cancer patient may have their own unique mutations, even if they have the same type of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the trend in targeted therapies for cancer?

A

There has been a huge increase in small molecule inhibitors that inhibit specific cancers.

These targeted therapies are designed to attack specific genetic mutations found in cancer cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is The Cancer Genome Atlas (TCGA)?

A

A cancer sequencing project collecting tissues from 11,000 patients

TCGA provides genomic data for various cancers, facilitating research and treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When did The Cancer Genome Atlas project start and complete?

A

Started in 2009 and completed in 2016

This timeline reflects the extensive research and data collection involved in the project.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How many patients’ tissues were collected for The Cancer Genome Atlas?

A

11,000 patients

This large sample size allows for a comprehensive analysis of cancer genomics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of cancers were studied in The Cancer Genome Atlas?

A

Cancers included:
* Brain (Glioma, Glioblastoma)
* Breast
* Gastrointestinal (Colon, Rectal, Stomach)
* Gynaecologic (Ovarian, Cervical, Uterine)
* Head and Neck
* Hematologic (AML)
* Melanoma
* Lung
* Urologic (Kidney, Prostate)

These categories encompass a wide range of cancer types for comprehensive research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where is all TCGA data currently stored?

A

Genomic Data Commons

The GDC portal provides public access to genomic data for further research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the European equivalent of The Cancer Genome Atlas?

A

COSMIC

COSMIC (Catalog of Somatic Mutations in Cancer) is a database of somatic mutations in cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of data was primarily compared in The Cancer Genome Atlas?

A

Cancer biopsies and normal biopsies

This comparison helps identify genetic differences that may drive cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What percentage of patients in TCGA were subjected to whole genome sequencing?

A

22%

This indicates a focused approach on a subset of patients for detailed genomic analysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

True or False: The data from The Cancer Genome Atlas is freely available.

A

True

This accessibility supports global research initiatives in cancer biology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the purpose of cancer genome sequencing?

A

To identify key mutations by comparing tumor DNA/RNA to normal DNA/RNA

This process helps in understanding the genetic variations specific to cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What samples are typically collected for cancer genome sequencing?

A

Tumor biopsy and normal biopsy taken at the same time

This dual sampling allows for a direct comparison between cancerous and healthy cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why is it important to differentiate between normal genetic variation and cancer mutations?

A

To accurately identify mutations that contribute to cancer development

Genetic variation can exist in everyone, making it crucial to distinguish between benign variations and those that indicate cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is one of the main analyses performed during cancer genome sequencing?

A

Sequencing and alignment to a reference genome

This step helps in identifying mutations by comparing sequenced data against a standard genome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the role of treatments available for common cell signaling inhibitors?

A

To target specific pathways involved in cancer cell proliferation

These treatments aim to disrupt the signals that promote tumor growth.

24
Q

Fill in the blank: Cancer genome sequencing involves the analysis of _______ and RNA.

A

DNA

DNA analysis is a critical component in understanding the genetic basis of cancer.

25
Q

True or False: Tumor and normal biopsies are collected at different times during cancer genome sequencing.

A

False

Both biopsies are collected simultaneously for accurate comparison.

26
Q

What is a key step in the integration and interpretation phase of cancer genome sequencing?

A

Identifying genetic variations that are specific to cancer

This step assists in determining the relevance of identified mutations.

27
Q

What does the term ‘cell proliferation’ refer to in the context of cancer?

A

The process of cancer cells multiplying and growing

Understanding cell proliferation is essential for developing effective treatments.

28
Q

How many single nucleotide variations (SNVs) are typically found in many cancer types?

A

10-100,000 SNVs

This range indicates the high variability of mutations present in different cancers.

29
Q

How many cancer genes have been identified?

A

> 400 cancer genes

This includes well-known genes associated with various cancers.

30
Q

Name three of the most common cancer genes.

A
  • p53
  • RB1
  • KRAS
  • BRCA1/2

These genes are frequently studied due to their roles in cancer development.

31
Q

True or False: Every patient with cancer has the same spectrum of mutations.

A

False

Each patient exhibits a unique selection of mutations.

32
Q

What is the significance of the 100,000 genome project in cancer genomics?

A

It helps determine normal variation vs cancer variations

This project aids in distinguishing between benign genetic variations and those associated with cancer.

33
Q

What are common structural variants found in cancer?

A
  • Deletions
  • Rearrangements of genes

These structural changes can significantly impact gene function and contribute to cancer progression.

34
Q

Fill in the blank: Every patient often has one common mutation associated with the disease along with ______ mutations specific to that individual.

A

10-20 other mutations

This highlights the complexity of cancer genetics and individual patient profiles.

35
Q

What is the challenge in distinguishing between normal genetic variation and cancer-related mutations?

A

Hard to figure out what is normal variation and what is cancer

The overlap between benign and malignant genetic changes complicates diagnosis and treatment.

36
Q

Cite one key publication related to cancer genomics from the Cancer Genome Atlas Research Network.

A

Nature 474, 603-15 (2011)

This publication integrates genomic analyses of ovarian carcinoma.

37
Q

What types of mutations are often present in cancer?

A

Single nucleotide variations and structural variants

Both types of mutations play significant roles in cancer development and progression.

38
Q

What are common pathways where mutations often fall?

A
  • Wnt
  • PI3K/AKT
  • Ras/Raf
  • TP53
  • RB

These pathways are critical in various cellular processes and are frequently implicated in cancer development.

39
Q

How many key pathways are mentioned in the context of mutations?

A

12

The specific pathways are important for understanding the molecular basis of different cancers.

40
Q

True or False: Different types of cancer can have the same mutated gene.

A

True

An example is the EGFR gene, which can be mutated in both non-small cell lung cancer (NSCLC) and colon cancer.

41
Q

What is a common outcome from sequencing in cancer research?

A

Finding a potentially ‘druggable’ mutation

This refers to mutations that can be targeted by specific therapies.

42
Q

Fill in the blank: Different kinds of cancers can have the same gene mutated, e.g., _______ in NSCLC and colon cancer.

A

EGFR

EGFR stands for Epidermal Growth Factor Receptor, a significant target in cancer treatment.

43
Q

What are some examples of genetic variations associated with cancer?

A
  • EGFR mutations
  • HER2 mutations
  • BRAF mutations
  • MET amplification
  • RET rearrangements

These genetic variations can influence treatment options and patient responses.

44
Q

Name some targeted therapy agents used in cancer treatment.

A
  • Gefitinib
  • Erlotinib
  • Afatinib
  • Trastuzumab
  • Vemurafenib
  • Dabrafenib
  • Crizotinib
  • Cabozantinib

These agents are designed to target specific genetic mutations in cancer cells.

45
Q

True or False: Only some lung cancer patients have EGFR gene mutations.

A

True

Only patients with these mutations will respond to drugs targeting them.

46
Q

What is the importance of identifying mutations in cancer patients?

A

It allows for the possibility of treating with specific inhibitors.

Knowing the sequence of mutations can guide targeted therapy.

47
Q

Fill in the blank: Protein kinases transfer _____ from one protein to another.

A

Ks

This function is crucial in various cellular processes, including cell division.

48
Q

What is the potential outcome of blocking protein kinases in cancer treatment?

A

It can stop cells from dividing.

Inhibiting these kinases can disrupt cancer cell proliferation.

49
Q

What is the focus of the development of small-molecule inhibitor drugs?

A

Targeting mutated protein kinases.

These drugs are designed to interfere with specific pathways involved in cancer.

50
Q

What is the mechanism of action of Gleevec in treating CML?

A

Gleevec binds to the active site of Abl protein kinase and inhibits its activity

This inhibition leads to remission in Chronic Myeloid Leukemia.

51
Q

What chromosome translocation is involved in Chronic Myeloid Leukemia?

A

BCR-ABL translocation

This translocation results in the hyperexpression of a protein kinase.

52
Q

What other kinases can Gleevec bind to besides Abl?

A

Kit

Gleevec can also be used to treat cancers with Kit mutations.

53
Q

True or False: Gleevec has been on the market for a long time and is well studied.

A

True

Gleevec has a long history of use and research.

54
Q

What percentage of patients can build up resistance to Gleevec?

A

20%

This resistance can limit the effectiveness of the treatment.

55
Q

Fill in the blank: Gleevec is primarily used to treat ______ in patients.

A

[Chronic Myeloid Leukemia]

CML is a type of cancer that affects the blood and bone marrow.

56
Q

What has the success of Gleevec led to in the pharmaceutical industry?

A

The funding of many other small molecule inhibitors

Gleevec’s success created a significant market for targeted cancer therapies.

57
Q

What type of drug is Gleevec considered?

A

A small molecule inhibitor

It specifically targets certain proteins involved in cancer cell proliferation.